title: Percutaneous coronary interventions in the diabetic patient: where do we stand?
authors: From the Munroe Heart and Vascular Institute, Munroe Regional Medical Center, Ocala, FL. jabittl@mac.com.
authors: John A
authors: JA
authors: Bittl
mesh_terms: D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage; D002986:Clinical Trials as Topic; D048909:Diabetes Complications / Q000517:prevention & control*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage; D007328:Insulin / Q000008:administration & dosage / Q000009:adverse effects; D062645:Percutaneous Coronary Intervention; D011183:Postoperative Complications / Q000517:prevention & control*; D011725:Pyridines / Q000378:metabolism; D016896:Treatment Outcome
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D007328:Insulin; D011725:Pyridines; C446540:thienopyridine
keywords: angioplasty, balloon, coronary; coronary artery disease; diabetes mellitus; stents